Nathan Skorick

Director of Business Development, Infinx
Dallas-Fort Worth Metroplex,United States
Find Nathan Skorick's Email
Find Nathan Skorick's Phone

Who Is Nathan Skorick?

Total Experience19 years
CompanyInfinx
CountryUnited States

Nathan Skorick is a seasoned business development professional with extensive experience in the healthcare technology sector. Currently serving as the Director of Business Development at Infinx, he focuses on leveraging AI and ML to improve healthcare business processes. Prior to Infinx, Nathan held business development roles at MDsave, Clinithink, Integra Connect, RemitDATA, and Altos Solutions, demonstrating a consistent track record of driving growth and building strategic partnerships.

How Did Nathan Skorick's Career Path Shape Their Journey?

Nathan Skorick's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Infinx - Director of Business Development(2023 to Present)
MDsave, Inc. - Business Development Manager(2021 to 2023)
Clinithink - VP Sales, Healthcare Solutions(2018 to 2020)
Integra Connect - Vice President Enterprise Sales(2016 to 2017)
RemitDATA - Vice President Business Development(2015 to 2016)
Clinithink, LTD - Business Development Executive(2012 to 2015)
Altos Solutions - Regional Account Manager(2011 to 2012)

What Are Nathan Skorick's Key Achievements?

Director of Business Development at Infinx

Leading business development efforts at Infinx, focusing on AI and ML solutions for healthcare. Developing and implementing strategies to expand market reach and drive revenue growth.

Business Development Manager at MDsave, Inc.

Managed business development initiatives at MDsave, contributing to the company's growth and market presence in the healthcare sector.

VP Sales, Healthcare Solutions at Clinithink

Led sales efforts within the Healthcare solutions division at Clinithink.

What's Nathan Skorick's Educational Background?

Liberal Arts and Sciences, General Studies and Humanities

Lubbock Christian University - Year 1991

Buying Intent Signals for Nathan Skorick

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Infinx
Total employees1001-5000
HeadquartersSan Jose
Founded2012

Infinx provides AI-powered solutions for healthcare revenue cycle management, helping providers maximize revenue and optimize their financial performance. Their platform automates key processes, reduces errors, and improves efficiency across the revenue cycle.

Infinx Funding Information
Unknown - Total Funding Raised
Not applicable - Most recent funding amount
Not applicable - Number of funding rounds
Not applicable - Latest funding round

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.